Gene Therapy for Hemophilia B
Gene therapy for Hemophilia B in China offers a breakthrough approach using AAV-F9 delivery to restore natural clotting factor production, potentially reducing or eliminating lifelong factor IX infusions.
Gene therapy for Hemophilia B in China offers a breakthrough approach using AAV-F9 delivery to restore natural clotting factor production, potentially reducing or eliminating lifelong factor IX infusions.